FR2962043B1 - Composition cosmetique comprenant du peba - Google Patents

Composition cosmetique comprenant du peba

Info

Publication number
FR2962043B1
FR2962043B1 FR1055288A FR1055288A FR2962043B1 FR 2962043 B1 FR2962043 B1 FR 2962043B1 FR 1055288 A FR1055288 A FR 1055288A FR 1055288 A FR1055288 A FR 1055288A FR 2962043 B1 FR2962043 B1 FR 2962043B1
Authority
FR
France
Prior art keywords
peba
blocks
copolymer
perfumery
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1055288A
Other languages
English (en)
Other versions
FR2962043A1 (fr
Inventor
Frederic Malet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arkema France SA
Original Assignee
Arkema France SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1055288A priority Critical patent/FR2962043B1/fr
Application filed by Arkema France SA filed Critical Arkema France SA
Priority to PCT/FR2011/051509 priority patent/WO2012001298A1/fr
Priority to CN2011800326585A priority patent/CN102958496A/zh
Priority to EP11740962.3A priority patent/EP2588065A1/fr
Priority to US13/807,783 priority patent/US10105310B2/en
Priority to JP2013517453A priority patent/JP2013530204A/ja
Priority to KR1020137002010A priority patent/KR20130050955A/ko
Publication of FR2962043A1 publication Critical patent/FR2962043A1/fr
Application granted granted Critical
Publication of FR2962043B1 publication Critical patent/FR2962043B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
FR1055288A 2010-07-01 2010-07-01 Composition cosmetique comprenant du peba Expired - Fee Related FR2962043B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR1055288A FR2962043B1 (fr) 2010-07-01 2010-07-01 Composition cosmetique comprenant du peba
CN2011800326585A CN102958496A (zh) 2010-07-01 2011-06-29 包含peba的化妆品组合物
EP11740962.3A EP2588065A1 (fr) 2010-07-01 2011-06-29 Composition cosmetique comprenant du peba
US13/807,783 US10105310B2 (en) 2010-07-01 2011-06-29 Cosmetic composition comprising PEBA
PCT/FR2011/051509 WO2012001298A1 (fr) 2010-07-01 2011-06-29 Composition cosmetique comprenant du peba
JP2013517453A JP2013530204A (ja) 2010-07-01 2011-06-29 Ｐｅｂａを含む化粧組成物
KR1020137002010A KR20130050955A (ko) 2010-07-01 2011-06-29 Peba 를 포함하는 화장 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1055288A FR2962043B1 (fr) 2010-07-01 2010-07-01 Composition cosmetique comprenant du peba

Publications (2)

Publication Number Publication Date
FR2962043A1 FR2962043A1 (fr) 2012-01-06
FR2962043B1 true FR2962043B1 (fr) 2013-02-01

Family

ID=43088107

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1055288A Expired - Fee Related FR2962043B1 (fr) 2010-07-01 2010-07-01 Composition cosmetique comprenant du peba

Country Status (7)

Country Link
US (1) US10105310B2 (fr)
EP (1) EP2588065A1 (fr)
JP (1) JP2013530204A (fr)
KR (1) KR20130050955A (fr)
CN (1) CN102958496A (fr)
FR (1) FR2962043B1 (fr)
WO (1) WO2012001298A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2985515B1 (fr) * 2012-01-05 2013-12-20 Arkema France Solution liquide comprenant du peba.
JP6137904B2 (ja) * 2013-03-28 2017-05-31 住友精化株式会社 ポリアミド系ゴム弾性体球状粉体
FR3019747B1 (fr) * 2014-04-11 2017-08-25 Arkema France Utilisation de peba a blocs longs pour la fabrication de tout ou partie d'un catheter.
US10388407B2 (en) 2014-10-21 2019-08-20 uBiome, Inc. Method and system for characterizing a headache-related condition
US10366793B2 (en) 2014-10-21 2019-07-30 uBiome, Inc. Method and system for characterizing microorganism-related conditions
US9754080B2 (en) 2014-10-21 2017-09-05 uBiome, Inc. Method and system for microbiome-derived characterization, diagnostics and therapeutics for cardiovascular disease conditions
US10777320B2 (en) 2014-10-21 2020-09-15 Psomagen, Inc. Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions
US9760676B2 (en) 2014-10-21 2017-09-12 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions
US11783914B2 (en) 2014-10-21 2023-10-10 Psomagen, Inc. Method and system for panel characterizations
US10265009B2 (en) 2014-10-21 2019-04-23 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features
US10410749B2 (en) 2014-10-21 2019-09-10 uBiome, Inc. Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
US10409955B2 (en) 2014-10-21 2019-09-10 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics for locomotor system conditions
US10381112B2 (en) 2014-10-21 2019-08-13 uBiome, Inc. Method and system for characterizing allergy-related conditions associated with microorganisms
US9758839B2 (en) 2014-10-21 2017-09-12 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features
US10073952B2 (en) 2014-10-21 2018-09-11 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
WO2016065075A1 (fr) 2014-10-21 2016-04-28 uBiome, Inc. Procédé et système de diagnostic et de thérapie fondés sur le microbiome
US10357157B2 (en) 2014-10-21 2019-07-23 uBiome, Inc. Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features
US9710606B2 (en) 2014-10-21 2017-07-18 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues
US10789334B2 (en) 2014-10-21 2020-09-29 Psomagen, Inc. Method and system for microbial pharmacogenomics
CN107115242A (zh) * 2017-05-31 2017-09-01 合肥创沃科技有限公司 一种玛咖复合荞麦淀粉润肤乳液的制备方法
CN106963703A (zh) * 2017-05-31 2017-07-21 合肥创沃科技有限公司 一种荞麦甘草复合润肤乳液的制备方法
CN106983696A (zh) * 2017-05-31 2017-07-28 合肥创沃科技有限公司 一种荞麦黄瓜复合润肤乳液的制备方法
CN107184469A (zh) * 2017-05-31 2017-09-22 合肥创沃科技有限公司 一种三白草复合荞麦淀粉润肤乳液的制备方法
CN107115241A (zh) * 2017-05-31 2017-09-01 合肥创沃科技有限公司 一种荞麦淀粉润肤乳液的制备方法
EP3552986A1 (fr) * 2018-04-11 2019-10-16 Clariant Plastics & Coatings Ltd Composition polymère comprenant un polymère de base, un matériau actif et un additif
EP3797022A4 (fr) 2018-05-21 2022-02-23 O2 Partners, LLC Mousses microcellulaires flexibles moulées par injection biodégradables et compostables industriellement, et leur procédé de fabrication
US10843429B2 (en) 2018-05-21 2020-11-24 O2 Partners, Llc Biodegradable, industrially compostable, and recyclable injection molded microcellular flexible foams

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6010715A (en) * 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
US5652326A (en) 1993-03-03 1997-07-29 Sanyo Chemical Industries, Ltd. Polyetheresteramide and antistatic resin composition
SE9602529D0 (sv) * 1996-06-26 1996-06-26 Astra Ab Medical device
EP1128724B1 (fr) * 1998-11-12 2002-11-27 Bayer Aktiengesellschaft Amides de polyether sequence contenant des substances actives
DE60020710T2 (de) * 1999-06-11 2006-03-16 Dow Global Technologies, Inc., Midland Hydrierte blockcopolymerzusammensetzungen und verwendungen davon
DE19933279A1 (de) * 1999-07-14 2001-03-01 Biotronik Mess & Therapieg Polymerwerkstoff
US6638259B1 (en) * 1999-10-28 2003-10-28 Scimed Life Systems, Inc. Biocompatible medical devices
US6590065B1 (en) 2001-12-10 2003-07-08 E. I. Du Pont De Nemours And Company Polytrimethylene ether ester amide and use thereof
FR2846332B1 (fr) 2002-10-23 2004-12-03 Atofina Copolymeres transparents a blocs polyamides et blocs polyethers
US6956099B2 (en) * 2003-03-20 2005-10-18 Arizona Chemical Company Polyamide-polyether block copolymer
JP4193588B2 (ja) 2003-05-26 2008-12-10 宇部興産株式会社 ポリアミド系エラストマー
JP4161802B2 (ja) 2003-05-27 2008-10-08 宇部興産株式会社 ポリアミド組成物
US7056975B2 (en) 2003-05-27 2006-06-06 Ube Industries, Ltd. Thermoplastic resin composition having improved resistance to hydrolysis
FR2881431B1 (fr) 2005-01-28 2008-12-05 Arkema Sa Greffage d'une poudre de polyamide par irradiation gamma.
EP1655344A1 (fr) * 2004-11-05 2006-05-10 The Procter & Gamble Company Compositions polymères pour la diffusion prolongée de composés volatiles
US7919074B2 (en) * 2006-05-18 2011-04-05 Akzo Nobel N.V. Polyetheramide compositions
US20100234499A1 (en) 2006-08-18 2010-09-16 Norihiro Sugihara Aqueous dispersion of polyamide rubber elastic body and method of producing the same

Also Published As

Publication number Publication date
US10105310B2 (en) 2018-10-23
JP2013530204A (ja) 2013-07-25
FR2962043A1 (fr) 2012-01-06
KR20130050955A (ko) 2013-05-16
CN102958496A (zh) 2013-03-06
EP2588065A1 (fr) 2013-05-08
WO2012001298A1 (fr) 2012-01-05
US20130156833A1 (en) 2013-06-20

Similar Documents

Publication Publication Date Title
FR2962043B1 (fr) Composition cosmetique comprenant du peba
PH12015501320A1 (en) Fragrance materials
EP2576578A4 (fr) Formes polymorphiques du 2'-o-fucosyllactose et leurs procédés de production
TN2011000466A1 (en) Substituted 2-acetamido -5-aryl-1, 2, 4- triazolones and use thereof
FI20115758A0 (fi) Uusia viljatuotteita, niiden valmistus ja käyttö, ja niitä sisältäviä kosmeettisia formulaatioita
MX351211B (es) Sistemas de perfume.
MX2014011818A (es) Anticuerpos biespecificos contra inductor debil de la apoptosis relacionado con el tnf (tweak) humana e il17 humana y usos de los mismos.
WO2014030770A3 (fr) Copolymère présentant une structure de dendrimère carbosiloxane et un groupe hydrophile
MX343688B (es) Compuestos tricíclicos de sulfonamida y pirazolo y métodos para su fabricación y uso.
BR112014029286A2 (pt) composição cosmética sólida, processo para sua produção, produto e método cosmético
WO2011000866A3 (fr) Verres à composants multiples destinés à être utilisés dans des produits de soin
WO2013061004A8 (fr) Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines
MX2017006545A (es) Proceso para la preparacion de 1-(2,6,6-trimetilciclohexil)-alcan- 3-oles.
IN2015DN00239A (fr)
MX2014004858A (es) Compuestos de 3,4-diamino-3-ciclobuten-1,2-diona disustituidos utiles en el tratamiento de patologias mediadas por quimiocinas.
PH12015500847A1 (en) Oral care compositions
CR20120082A (es) Conservantes de derivados de quitina
MX365703B (es) Composicion acuosa rica en aceite y su uso en un metodo de decoloracion o coloracion oxidativa.
MX353099B (es) Metodo para producir particulas de polvo libre de poliamida impregnada con por lo menos un agente cosmetico o farmaceutico, y particulas de polvo libre de poliamida que tienen un contenido de por lo menos 25% en peso de por lo menos un agente cosmetico o farmaceutico diferente al agua.
CY1118198T1 (el) Παραγωγα παντοθενικου για την αντιμετωπιση νευρολογικων διαταραχων
MX2018016032A (es) Nuevo extracto de aquenio silybum marianum y usos del mismo en la dermatologia y dermocosmeticos.
PH12015500585A1 (en) Modified hyaluronic acid derivatives and use thereof
MX2015006936A (es) Sistemas de perfume.
MX339063B (es) Composiciones para suministrar perfume a la piel.
NZ756986A (en) Health food and cosmetics for increasing the amount of apoptosis cells and decreasing the amount of necrosis cells and a method of manufacturing a sprout-forcing grape seed-derived ingredient for increasing the amount of apoptosis cells and decreasing the amount of necrosis cells

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 11

ST Notification of lapse

Effective date: 20220305